FCN2 and infection: We propose that ficolin-2’s specific recognition of O-acetylated capsule glycopolymers (17) is the principal factor providing population-wide, innate serological protection against 11A IPD and spurring the convergent loss of capsular O-acetyltransferase genes across independent infections, while having negligible impact on 11A prevalence in NP carriage (Figure 4).